-
241
Exploring HIV provider framings of living and aging with HIV
Published 2025-06-01Get full text
Article -
242
-
243
Spatial Buffering Mechanism: Mathematical Model and Computer Simulations
Published 2005-09-01Get full text
Article -
244
-
245
Does Caregiver Engagement Predict Outcomes of Adolescent Wilderness Therapy?
Published 2025-01-01Get full text
Article -
246
To Measure or Not to Measure: Direct Oral Anticoagulant Laboratory Assay Monitoring in Clinical Practice
Published 2023-01-01Get full text
Article -
247
Health Canada's use of its priority review process for new drugs: a cohort study
Published 2015-05-01Get full text
Article -
248
Exploration of the Effect of Tobacco Smoking on Metabolic Measures in Young People Living with HIV
Published 2014-01-01Get full text
Article -
249
The WHO’s 75th anniversary: WHO at a pivotal moment in history
Published 2023-04-01Get full text
Article -
250
Macroscopic Modeling of On-Street and Garage Parking: Impact on Traffic Performance
Published 2019-01-01Get full text
Article -
251
Modified Weights-of-Evidence Modeling with Example of Missing Geochemical Data
Published 2018-01-01Get full text
Article -
252
-
253
-
254
Characterization of Neural Interaction During Learning and Adaptation from Spike-Train Data
Published 2004-10-01Get full text
Article -
255
-
256
Modified Whale Optimization Algorithm for Solar Cell and PV Module Parameter Identification
Published 2021-01-01Get full text
Article -
257
Update on Surgical Techniques Best Practices to Optimize Outcomes Following Gel Stent Implantation
Published 2025-01-01“…Vanessa Vera,1 Arsham Sheybani,2 Joseph F Panarelli,3 Davinder S Grover,4 James Lee,5 Earl Randy Craven,2 Thomas W Samuelson,6 Iqbal Ike K Ahmed7 1Allergan, an AbbVie company, Irvine, CA, USA; 2Washington University School of Medicine, St Louis, MO, USA; 3Department of Ophthalmology, New York University Langone Health, New York, NY, USA; 4Glaucoma Associates of Texas, Dallas, TX, USA; 5Colorado Eye Institute, Colorado Springs, CO, USA; 6Minnesota Eye Consultants, University of Minnesota, Minneapolis, MN, USA; 7John Moran Eye Center, University of Utah, Salt Lake City, UT, USACorrespondence: James Lee, Colorado Eye Institute, Colorado Springs, CO, 80924, USA, Email jlee@eyescolorado.comAbstract: The XEN® 45 Glaucoma Treatment System (gel stent; Allergan, an AbbVie company, Irvine, CA, USA) is a minimally invasive bleb-forming surgical device that was originally approved to lower intraocular pressure by diverting the aqueous humor from the anterior chamber to the subconjunctival space (like trabeculectomy) following ab-interno placement. …”
Get full text
Article -
258
-
259
Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer's Disease Risk: A Perspective Review
Published 2025-02-01Get full text
Article -
260
Analog Hawking radiation from a spin-sonic horizon in a two-component Bose–Einstein condensate
Published 2025-01-01Get full text
Article